Paula
Rodríguez Otero
Consultora Médica
University of Pittsburgh School of Medicine
Pittsburgh, Estados UnidosUniversity of Pittsburgh School of Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2022
-
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study
British Journal of Haematology, Vol. 196, Núm. 3, pp. 639-648
2021
-
Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 7, pp. 757-767